The investigation was prompted by a formal complaint from the Italian Sativa Hemp Association (CSI), which argued that the Italian government’s proposed restrictions on CBD-containing products, including those derived from “light cannabis” with THC levels below 0.2%, could infringe upon EU regulations.
In recent years, Italy has seen a boom in its hemp and CBD industry, with a market valued at approximately €500 million annually. The sector includes a wide range of products such as cosmetics, food supplements, herbal remedies, and wellness items. Italian law currently allows the cultivation and sale of hemp products containing less than 0.2% THC, the psychoactive compound found in cannabis. However, in a move aimed at tightening regulations around cannabis-derived substances, the Italian government, led by Prime Minister Giorgia Meloni, proposed a series of amendments to restrict the availability of CBD products in the country.
These restrictions include tighter controls on CBD extraction methods and the sale of products containing low levels of THC. The government’s stance is largely driven by concerns over public health and potential legal loopholes that could allow for broader cannabis use. However, the proposed measures have sparked backlash from industry leaders and cannabis advocates, who argue that they would stifle a growing market and conflict with existing EU regulations.
The European Commission is now investigating whether Italy’s proposed restrictions comply with EU law, particularly regarding the free movement of goods within the single market. According to EU regulations, any product legally produced and sold in one member state should be allowed to circulate freely across the bloc, unless there are justified public health or safety concerns. In the case of CBD, the European Court of Justice (ECJ) ruled in 2020 that CBD is not a narcotic and should not be treated as such, as long as it is derived from industrial hemp.
One of the key points under scrutiny is that the Italian government did not notify the European Commission about these proposed changes, as required under the EU’s “Technical Regulations Information System.” This failure to comply with procedural obligations could lead to further legal challenges from both the European Commission and industry stakeholders.
Italy’s CBD industry employs over 15,000 people, and many businesses fear that the new restrictions would severely damage the sector. Industry advocates argue that the move could cost Italy significant economic growth opportunities, especially in light of the increasing global demand for CBD products, known for their potential health benefits. The Italian Sativa Hemp Association has urged the Commission to act quickly, warning that the Italian government’s stance risks isolating the country from the EU’s broader cannabis market.
If Italy does not amend or withdraw its proposed restrictions, it could face infringement proceedings from the European Commission, potentially leading to a case in the European Court of Justice. The ECJ has already ruled in favor of the free movement of CBD within the EU in a previous case, reinforcing the notion that CBD products should be allowed to circulate freely as long as they comply with EU standards.
As the European Commission continues its investigation, the outcome could have far-reaching implications not only for Italy but for the entire European CBD market. Should the Commission rule against Italy’s measures, it would reinforce the rights of businesses to operate within a harmonized European market. Conversely, if the Commission finds the restrictions justified, it may lead to tighter controls across Europe regarding the production and sale of CBD products. In any case, the investigation highlights the ongoing tension between national governments and EU regulations on cannabis-related products, as well as the growing importance of CBD in both medicinal and wellness sectors across the continent.
Photo by JÉSHOOTS from Pexels
